Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday ...

CSL Limited (OTC:CSLLY) and Arcturus Therapeutics (NASDAQ:ARCT) announced the results of a Phase 3 head-to-head study of ARCT ...

In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...

Track the latest bird flu vaccine news, investments, and deals as biotechs respond to rising U.S. cases with innovative ...

Last year only 23% of Americans got an updated COVID-19 vaccine, according to the CDC. They recommend those six months and ...

The fall virus season is upon us, and the U.S. Food & Drug Administration just approved one of the newest tools to protect ...

Pfizer remains an attractive capital return play with a 10X P/E ratio, despite concerns about post-COVID revenue declines.

This is the first RSV vaccine approved in Singapore for use in older adults and pregnant individuals, providing critical ...

Pfizer-BioNTech's updated vaccine to protect against a recently circulating variant of COVID-19 is authorized, Health Canada said on Tuesday.

Pfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently ...

BioNTech’s updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine formulations that protect against ...